Study: Children with vision impairment have reduced quality of life

News
Article

Research from Orbis International analyses the overall wellbeing of children with common childhood vision problems

A child wearing glasses sits in a classroom among her peers who do not have glasses. Image credit: ©Drazen – stock.adobe.com

Orbis noted the impact of vision impairment on quality life and mental health. Image credit: ©Drazen – stock.adobe.com

Orbis International has released results of a study1 that found children with myopia and strabismus often experienced significantly reduced quality of life compared to those without vision impairment.

Published in Ophthalmology, the study also finds that surgical treatment of strabismus improves quality of life among children, underscoring the importance of early detection, treatment and health insurance coverage of strabismus for children.

According to a news release, the research received financial support from Santen, and the study is the first systematic review and meta-analysis of the links between quality of life in children and vision impairment, ocular morbidities and their treatment.

Moreover, Orbis noted in its release quality of life and mental health are increasingly being recognised as important global health concerns. With an estimated 70 million children experiencing vision impairment around the world, understanding the impact of these conditions on mental health is critical.1

The company noted that a child's vision function is assessed by clarity or sharpness of their vision. However, this approach does not measure a child's perception of their own visual impairment and ability to successfully complete daily tasks. For example, chronic eye conditions that may not affect central vision but have other negative impacts, like strabismus, have been shown to cause physical, educational and socioemotional difficulties in their daily lives.

This study is a companion research study2 published last year by Orbis, and also published in Ophthalmology, that found children with myopia and strabismus were diagnosed with higher rates of depression and anxiety than children without vision impairment.

"Our papers in Ophthalmology furnish the strongest evidence yet that impaired vision in children is associated with mental health problems, such as depression and anxiety," Prof Nathan Congdon, director of Research at Orbis International, said in the news release. "This latest study provides an even broader picture of a child's mental health, including quality of life, wellbeing, and self-esteem, meaning we now have a complete story about how a lack of vision care can cause mental health problems for a child."

Reference:

  1. Dongfeng LI, Ving Fai Chan, PhD, Gianni Virgili, PhD, et.al. Impact of Vision Impairment and Ocular Morbidity and Their Treatment on Quality of Life in Children: A Systemic Review.Ophthalmology. Published September 9, 2023. Accessed September 14, 2023. DOI: 10.1016/j.ophtha.2023.09.005.
  2. Dongfeng Li, Ving Fai Chan, PhD, Gianni Virgili, PhD. Impact of Vision Impairment and Ocular Morbidity and Their Treatment on Depression and Anxiety in Children. Ophthalmology. Published October 2022. Accessed September 14, 2023. DOI: 10.1016/j.ophtha.2022.05.020.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.